Hello,
Despite our efforts in drug development, we often face situations where promising projects fail. Some failures could have been anticipated and avoided, but a lack of experience and technology often results in unfortunate outcomes.

Drug development is often regarded as a 'failure-prone industry.’ However, effectively managing these failures is crucial. Effective risk management depends on leveraging accumulated experience and knowledge to make scientifically informed and predictable decisions regarding toxicity.

The CND (Center for Non-clinical Development) was established to address the task assigned by the Ministry of Trade, Industry, and Energy to reduce failures in drug development by building an incident evaluation platform and offering related services. Although the initial project has been completed, we remain committed to sustaining the educational initiatives led by CND.

Our laboratory is dedicated to identifying and addressing toxicological challenges faced by drug developers, with the goal of enhancing new drug success rates and sharing our cultivated technology and expertise. We appreciate your ongoing interest and support in our efforts to enhance our nation’s toxicology capabilities.
Thank you.

서울아산병원